NewsRx

Search our medical news database

Arthritis

Gene Transfer of sIL-1ra DNA into Joint Synovium Suppresses Arthritis

Published in Gene Therapy Weekly, February 5th, 1996

An animal model provides experimental evidence for the feasibility of antiinflammatory gene therapy for rheumatoid arthritis (RA).

The cytokine interleukin 1 (IL-1) plays an important role in the pathogenesis of human RA. The naturally occurring antagonist of IL-1, recombinant human secreted interleukin 1 receptor antagonist (sIL-1ra), is a glycoprotein which competitively binds IL-1 receptors without eliciting cell activation. Previous research has shown the therapeutic benefit of systemically administering sIL-1ra for treatment of rheumatoid arthritis.

Sergei S. Makorov et al. proposed that rather than the daily systemic delivery of sIL-1ra to...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook